Bone loss after cardiac transplantation.
D019386:Alendronate / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D015519:Bone Density; D001862:Bone Resorption / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D002117:Calcitriol / Q000627:therapeutic use*; D003094:Collagen / Q000097:blood; D024042:Collagen Type I; D050723:Fractures, Bone / Q000517:prevention & control; D016027:Heart Transplantation; D006801:Humans; D010281:Parathyroid Hormone / Q000097:blood; D010455:Peptides / Q000097:blood; D011183:Postoperative Complications / Q000517:prevention & control*
D015415:Biomarkers; D024042:Collagen Type I; D010281:Parathyroid Hormone; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D003094:Collagen; D002117:Calcitriol; D019386:Alendronate